Capital Advisors Ltd’s Celgene Corp CELG Stock Holding History

Capital Advisors Ltd’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200	Closed	-$20K	–	433
2019 Q3	$20K	Hold	200	–	–	0.01%	307
2019 Q2	$18K	Hold	200	–	–	0.01%	344
2019 Q1	$19K	Hold	200	–	–	0.01%	337
2018 Q4	$13K	Hold	200	–	–	﹤0.01%	363
2018 Q3	$18K	Hold	200	–	–	0.01%	373
2018 Q2	$16K	Hold	200	–	–	0.01%	304
2018 Q1	$18K	Hold	200	–	–	0.01%	285
2017 Q4	$21K	Hold	200	–	–	0.01%	278
2017 Q3	$29K	Hold	200	–	–	0.01%	256
2017 Q2	$26K	Hold	200	–	–	0.01%	267
2017 Q1	$25K	Hold	200	–	–	0.01%	246
2016 Q4	$23K	Hold	200	–	–	0.01%	246
2016 Q3	$21K	Buy	+200	New	+$21.6K	0.01%	251

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Capital Advisors Ltd's CELG Position: Q4 2019 in Review

Capital Advisors Ltd sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 200 shares — an estimated $20K sold.

Capital Advisors Ltd first reported a position in CELG in Q3 2016 and held it in 13 quarters. The position peaked at $29K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Capital Advisors Ltd reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Capital Advisors Ltd sold 200 Celgene Corp shares in Q4 2019, an estimated $20K.
Capital Advisors Ltd first reported a position in Celgene Corp in Q3 2016 and held it in 13 quarters.
Capital Advisors Ltd's Celgene Corp position peaked at $29K in Q3 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Capital Advisors Ltd's 13F filing for Q4 2019, filed 3 Feb 2020.